| 英文別名： |
N,N-Dimethyl-2-(phenyl(o-tolyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;orphenadrine dihydrogen citrate;Orphenadrine Citrate Salt;Orphenadrine (citrate);Orphenadrine Citrate;beta-Dimethylaminoethyl 2-methylbenzhydryl ether citrate;o-Methyldiphenhydramine citrate;Orphenadrine citrate;o-Methyldiphenhydramine citrate salt;ORPHENGESIC FORTE COMPONENT ORPHENADRINE CITRATE;(+/-)-N,N-DIMETHYL-2-((O-METHYL-alpha-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1);ORPHENADRINE CITRATE [EP MONOGRAPH];(+-)-N,N-Dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate (1:1);NCGC00254980-01;NSC757238;Flexor;N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate;Orphenadrinecitrate;ORPHENADRINE CITRATE COMPONENT OF ORPHENGESIC;Tox21_111323_1;D00774;citric acid; N,N-dimethyl-2-[o-tolyl(phenyl)methoxy]ethanamine;(+-)-N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)ethylamine citrate;ORPHENADRINE CITRATE [WHO-DD];HMS3259M21;Orphenadrine citrate [USP];S2054;ORPHENGESIC COMPONENT ORPHENADRINE CITRATE;MLS000069549;HMS502K15;HMS3651A10;ORPHENADRINE CITRATE COMPONENT OF INVAGESIC;FT-0655842;Tega-Flex;X-Otag;4596-23-0;Banflex;Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate(1:1);Ethylamine, N,N-dimethyl-2-((o-methyl-alpha-phenylbenzyl)oxy)-, citrate (1:1);EINECS 225-137-5;Tox21_301079;ORPHENADRINE CITRATE [EP IMPURITY];NCGC00015771-13;ORPHENADRINE CITRATE [MI];Citrate, Orphenadrine;ORPHENADRINE CITRATE [ORANGE BOOK];Z234896463;Ethanamine, N,N-dimethyl-2-[(2-methylphenyl)phenylmethoxy]-,2-hydroxy-1,2,3-propanetricarboxylate (1:1);Q27107584;X0A40N8I4S;C75247;N,N-dimethyl-2-(phenyl(o-tolyl)methoxy)ethan-1-amine 2-hydroxypropane-1,2,3-tricarboxylate;SPECTRUM1500447;DTXSID8044678;CHEMBL1200395;CHEBI:7790;ORPHENADRINE CITRATE (USP MONOGRAPH);N,N-dimethyl-2-[(2-methylphenyl)(phenyl)methoxy]ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;SR-01000002975-5;ORPHENADRINE CITRATE COMPONENT OF ORPHENGESIC FORTE;N,N-dimethyl-2-((2-methylphenyl)(phenyl)methoxy)ethanamine 2-hydroxypropane-1,2,3-tricarboxylate;NCGC00094745-03;Pharmakon1600-01500447;Norflex;C24H31NO8;INVAGESIC COMPONENT ORPHENADRINE CITRATE;FT-0673305;(+/-)-N,N-DIMETHYL-2-((O-METHYL-.ALPHA.-PHENYLBENZYL)OXY)ETHYLAMINE CITRATE (1:1);Norflex (TN);CAS-4682-36-4;A826945;Tox21_111323;ORPHENADINE CITRATE;NS00082653;NCGC00094745-02;HMS3370M12;Euflex;Orphenadrine citrate salt;Plenactol;INVAGESIC FORTE COMPONENT ORPHENADRINE CITRATE;SMR000058817;Tox21_113543;HMS2231J06;EN300-53019;Flexon;UNII-X0A40N8I4S;HY-B0369A;HMS3884M22;SCHEMBL119470;ORPHENADRINE CITRATE COMPONENT OF NORGESIC;AS-74807;ORPHENADRINE CITRATE (MART.);HMS1920D10;Ethanamine, N,N-dimethyl-2-((2-methylphenyl)phenylmethoxy)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1);Orphenadrine citrate (Norflex);NSC 757238;NORGESIC COMPONENT ORPHENADRINE CITRATE;ORPHENADRINE CITRATE (EP ... |
滬公網(wǎng)安備31011402010658號 
